Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Dino's Bar & Grill -- Ignore unavailable to you. Want to Upgrade?

To: Goose94 who wrote (50491)	3/21/2019 5:11:52 PM
From: Goose94	Read Replies (1) \| Respond to of 202922

Canada House Wellness Group (CHV-Cse) Builds on Sales License, Closes Oversubscribed $3.3 Million Unit Financing Mar 21, '19 - NR Canada House Wellness Group is pleased to announce that it has closed its financing of units (“Units”) resulting in total gross proceeds to the Company of $3,300,000 (the “Offering”). The Offering was oversubscribed beyond the $3 million maximum Offering initially announced by the Company. Each Unit was sold at a price of $0.12 per Unit and is comprised of: (i) one common share (each a “Common Share”); and (ii) and one detachable common share purchase warrant of the Company (each, a “Warrant”). Each Warrant is exercisable into one Common Share at an exercise price of $0.30 for a period of 12 months; at an exercise price of $0.40 from 12 months to 24 months; at an exercise price of $0.60 from 24 months to 36 months; and at an exercise price of $0.80 from 36 months to 48 months following the closing date of the Offering. The Company paid finders’ fees to appropriately registered entities in respect of investors introduced to the Company by such finders in the aggregate amount of $21,900. The Company also issued in aggregate 182,500 warrants having terms substantially similar to the Warrants in respect of subscriptions introduced to the Company by such finders. The net proceeds from the financing are expected to be used to provide clinic expansion capital for Canada House Clinics; Acquisition and developments costs for the Issuer’s Vegreville and Pickering facilities; R&D capital for its Knalysis Technologies division, and support of Canada House Clinics’ new client acquisition program implementation, and for general working capital purposes. “This fundraising strengthens our balance sheet and sets us up to pursue the next phase of growth initiatives which include materially expanding our production capacity and buildout of our extraction lab in partnership with Nutritional High which we expect will result in oils and extracts coming to market this calendar year. We were very pleased with the market’s interest in the Offering which acknowledges the strength of our story as a growing and impactful medical cannabis company entering into full commercial production” said Chris Churchill-Smith, CEO of Canada House. The Common Shares and Warrants (including Warrants issued to finders) issued pursuant to the Offering, and any common shares issued on the exercise of the Warrants will be subject to a statutory hold period in Canada of four months and one day following the closing of the Offering in accordance with applicable securities laws. Additional resale restrictions may be applicable under the laws of other jurisdictions, if any. Certain subscribers under the Offering were “related parties” to the Company and, accordingly, the Offering may be deemed to be a “related party transaction” as defined under Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions (“MI 61-101”). Other than subscription agreements between such related parties and the Company relating to the issuance of the Units pursuant to the Offering, the Company has not entered into any agreement with an interested party or a joint actor with an interested party in connection with the Offering. The Offering is exempt from the formal valuation and minority shareholder approval requirements of MI 61-101 (pursuant to subsections 5.5(a) and 5.7(1)(a)) as the fair market value of the related party transactions are not more than 25% of the market capitalization of the Company. This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein, and these securities will not be offered or sold in any jurisdiction in which their offer or sale would be unlawful. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “1933 Act”), or any state securities laws of the United States. Accordingly, these securities will not be offered or sold to persons within the United States unless an exemption from the registration requirements of the 1933 Act and applicable state securities laws is available. Canada House Wellness Group Inc. Canada House is the parent company of Marijuana for Trauma Inc., Knalysis Technologies and Abba Medix Corp. The Company's goal is to become a marketplace leader through strategic partnerships, mergers, and acquisitions to create a fully integrated cannabis therapy company. For more information please visit http://www.canadahouse.ca. or www.sedar.com For further information, please contact: Boom Capital Markets Steve Low 647-620-5101 steve@boomcapitalmarkets.com Canada House Wellness Group Inc. Chris Churchill-Smith, CEO 514-313-0102 chris.smith@canadahouse.ca